IODVA1, a Guanidinobenzimidazole Derivative, Targets Rac Activity and Ras-Driven Cancer Models

PLoS ONE - United States
doi 10.1371/journal.pone.0229801
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

G Protein Subunit-Dependent Rac-Guanine Nucleotide Exchange Activity of Ras-Grf1/CDC25Mm

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1999English

Stressing Rac, Ras, and Downstream Heat Shock Protein 70

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2000English

Antitumor Activity in RAS-Driven Tumors by Blocking AKT and MEK

Clinical Cancer Research
Cancer ResearchOncology
2014English

Exploiting Cancer Cell Vulnerabilities to Develop a Combination Therapy for Ras-Driven Tumors

Cancer Cell
Cancer ResearchOncologyCell Biology
2011English

Identification of Cancer Initiating Cells in K-Ras Driven Lung Adenocarcinoma

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2013English

Targeting Ras-Driven Cancer Cell Survival and Invasion Through Selective Inhibition of DOCK1

Cell Reports
BiochemistryGeneticsMolecular Biology
2017English

KRAS-Driven Metabolic Rewiring Reveals Novel Actionable Targets in Cancer

Frontiers in Oncology
Cancer ResearchOncology
2019English

CXL146, a Novel 4h-Chromene Derivative, Targets GRP78 to Selectively Eliminate Multidrug Resistant Cancer Cells

Molecular Pharmacology
Molecular MedicinePharmacology
2020English

Molecular Targets in Urothelial Cancer: Detection, Treatment, and Animal Models of Bladder Cancer

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy